Allergy Relief-d Tablet, Film Coated, Extended Release
Product Images NDC 68016-531

1 FDA label image from Chain Drug Consortium,llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Allergy Relief-d (NDC 68016-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Consortium,llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (24 Tablet Blister Pack Carton)

Principal Display Panel (24 Tablet Blister Pack Carton)
Allergy relief-D 5 mg / 120 mg extended-release film-coated tablets carton by Chain Drug Consortium, LLC. The label shows it contains cetirizine hydrochloride and pseudoephedrine hydrochloride for allergy and congestion relief. The package includes 24 tablets (4 blister cards of 6 tablets each) and highlights 12-hour symptom relief of runny nose, sneezing, itchy eyes, itchy throat or nose, sinus pressure, and nasal congestion. The Premier Value brand logo and drug facts panels with usage, directions, and warnings are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.